Apontis Pharma AG Bearer Shares APPH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €8.16
- Day Range
- €8.16–8.16
- 52-Week Range
- €2.82–27.30
- Bid/Ask
- €7.74 / €8.34
- Market Cap
- €69.36 Mil
- Volume/Avg
- 0 / 7,415
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.88
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 177
- Website
- https://www.apontis-pharma.de
Comparables
Valuation
|
Metric
|
APPH
|
ILM1
|
PSG
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 13.95 | 16.65 |
Price/Book Value | 2.29 | 0.72 | 6.88 |
Price/Sales | 1.88 | 0.19 | 2.59 |
Price/Cash Flow | — | 9.49 | 10.06 |
Price/Earnings
APPH
ILM1
PSG
Financial Strength
|
Metric
|
APPH
|
ILM1
|
PSG
|
|---|---|---|---|
Quick Ratio | 2.49 | 2.47 | 2.05 |
Current Ratio | 3.21 | 3.23 | 2.56 |
Interest Coverage | −212.95 | 13.03 | 5.54 |
Quick Ratio
APPH
ILM1
PSG
Profitability
|
Metric
|
APPH
|
ILM1
|
PSG
|
|---|---|---|---|
Return on Assets (Normalized) | −19.86% | 3.09% | 11.49% |
Return on Equity (Normalized) | −30.86% | 4.09% | 46.71% |
Return on Invested Capital (Normalized) | −29.80% | 4.08% | 48.84% |
Return on Assets
APPH
ILM1
PSG
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Dngrsybhv | Mbpw | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Dqrlygczv | Xjnnnmd | $68.1 Bil | |
HLN
| Haleon PLC ADR | Rrxwpqn | Qmskl | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Ykmbcjks | Vcbcv | $14.3 Bil | |
VTRS
| Viatris Inc | Ckjqkdfx | Jbsfy | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Fcwsxnykb | Knxg | $12.0 Bil | |
CTLT
| Catalent Inc | Nrqmfwz | Tgnkvz | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Ckrstlmc | Wfygd | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Bnpkjrly | Pzxww | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Chlspxsx | Nqhxgj | $3.4 Bil |